Martin Lehmann
DSM
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Martin Lehmann.
FEBS Journal | 2009
Martin Lehmann; Simone Degen; Hans-Peter Hohmann; Markus Wyss; Adelbert Bacher; Nicholas Schramek
GTP cyclohydrolase II catalyzes the first dedicated step in the biosynthesis of riboflavin and appears to be a limiting factor for the production of the vitamin by recombinant Bacillus subtilis overproducer strains. Using error‐prone PCR amplification, we generated a library of the B. subtilis ribA gene selectively mutated in the GTP cyclohydrolase II domain. The ratio of the GTP cyclohydrolase II to 3,4‐dihydroxy‐2‐butanone synthase activities of the mutant proteins was measured. A mutant designated Construct E, carrying seven point mutations, showed a two‐fold increase in GTP cyclohydrolase II activity and a four‐fold increase in the Km value with GTP as the substrate. Using the analog 2‐amino‐5‐formylamino‐6‐ribosylamino‐4(3H)‐pyrimidinone 5′‐triphosphate as the substrate, the mutant showed a rate enhancement by a factor of about two and an increase in the Km value by a factor of about 5. A series of UV absorption spectra obtained in stopped‐flow experiments using the wild‐type and mutant enzymes revealed isosbestic points indicative of apparently perfect reactions, which were similar to the findings obtained with GTP cyclohydrolase II of Escherichia coli. Initial burst velocities obtained for the mutant and wild‐type proteins were similar. The data suggest that the mutations present in Construct E are jointly conducive to the acceleration of a late step in the reaction trajectory, most probably the release of product from the enzyme.
BMC Biotechnology | 2011
Sabrina Hemberger; Danielle Biscaro Pedrolli; Jürgen Stolz; Christian Vogl; Martin Lehmann; Matthias Mack
BackgroundThe bacterium Bacillus subtilis, which is not a natural riboflavin overproducer, has been converted into an excellent production strain by classical mutagenesis and metabolic engineering. To our knowledge, the enhancement of riboflavin excretion from the cytoplasm of overproducing cells has not yet been considered as a target for (further) strain improvement. Here we evaluate the flavin transporter RibM from Streptomyces davawensis with respect to improvement of a riboflavin production strain.ResultsThe gene ribM from S. davawensis, coding for a putative facilitator of riboflavin uptake, was codon optimized (ribMopt) for expression in B. subtilis. The gene ribMopt was functionally introduced into B. subtilis using the isopropyl-β-thiogalactopyranoside (IPTG)-inducible expression plasmid pHT01: Northern-blot analysis of total RNA from IPTG treated recombinant B. subtilis cells revealed a ribMopt specific transcript. Western blot analysis showed that the his6-tagged heterologous gene product RibM was present in the cytoplasmic membrane. Expression of ribM in Escherichia coli increased [14C]riboflavin uptake, which was not affected by the protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP). Expression of ribMopt supported growth of a B. subtilis ΔribB::Ermr ΔribU::Kanr double mutant deficient in riboflavin synthesis (ΔribB) and also deficient with respect to riboflavin uptake (ΔribU). Expression of ribMopt increased roseoflavin (a toxic riboflavin analog produced by S. davawensis) sensitivity of a B. subtilis ΔribU::Kanr strain. Riboflavin synthesis by a model riboflavin B. subtilis production strain overproducing RibM was increased significantly depending on the amount of the inducer IPTG.ConclusionsThe energy independent flavin facilitator RibM could in principle catalyze riboflavin export and thus may be useful to increase the riboflavin yield in a riboflavin production process using a recombinant RibM overproducing B. subtilis strain (or any other microorganism).
Archive | 2004
Renyunan Bai; Markus Hümbelin; Martin Lehmann; Rual Lopez-Ulibarri; Markus Wyss
Archive | 2008
Martin Lehmann; Zoltan Pragai; Michèle Schaber
Archive | 2009
Martin Lehmann; Hans-Peter Hohmann; Dietmar Laudert; Michael Hans
Archive | 2010
Hans-Peter Hohmann; Martin Lehmann; Muriel Merkamm; Denis Pompon
Archive | 2006
Michael Hans; Dietmar Laudert; Hans-Peter Hohmann; Martin Lehmann
New Biotechnology | 2014
Holly Stolterfoht; Barbara Petschacher; Katharina Littringer; Martin Lehmann; Hans-Peter Hohmann; Harald Pichler
Archive | 2010
Hans-Peter Hohmann; Martin Lehmann; Muriel Merkamm; Denis Pompon
Archive | 2006
Martin Lehmann; Hans-Peter Hohmann; Dietmar Laudert; Michael Hans